MacroGenics, Inc.

MGNX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$67-$9-$120-$202
Dep. & Amort.$8$10$12$11
Deferred Tax$0$0$0$0
Stock-Based Comp.$29$0$20$23
Change in WC$1$53-$6$18
Other Non-Cash-$40-$132$7$6
Operating Cash Flow-$68-$78-$87-$144
Investing Activities
PP&E Inv.-$4-$2-$4-$6
Net Acquisitions$0$0$0$0
Inv. Purchases-$77-$240-$121-$231
Inv. Sales/Matur.$190$161$195$201
Other Inv. Act.$40$0$0$0
Investing Cash Flow$149-$80$71-$37
Financing Activities
Debt Repay.$0-$0$0$0
Stock Issued$0$1$1$118
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$149$1$5
Financing Cash Flow$1$150$2$123
Forex Effect$0$0$0$0
Net Chg. in Cash$82-$8-$15-$58
Supplemental Information
Beg. Cash$101$109$123$181
End Cash$183$101$109$123
Free Cash Flow-$72-$80-$91-$150
MacroGenics, Inc. (MGNX) Financial Statements & Key Stats | AlphaPilot